相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。International Consensus Guidance for Management of Myasthenia Gravis 2020 Update
Pushpa Narayanaswami et al.
NEUROLOGY (2021)
Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
Havard Fretheim et al.
PLOS ONE (2020)
AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review
Eamonn M. M. Quigley et al.
GASTROENTEROLOGY (2020)
Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients
Kookwan Sawadpanich et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2019)
Effect of probiotics on gastrointestinal symptoms and immune parameters in systemic sclerosis: a randomized placebo-controlled trial
Thais Fernandes Marighela et al.
RHEUMATOLOGY (2019)
Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment
Frederick B. Vivino et al.
CLINICAL IMMUNOLOGY (2019)
British Society of Gastroenterology guidelines for oesophageal manometry and oesophageal reflux monitoring
Nigel J. Trudgill et al.
GUT (2019)
Prucalopride for the treatment of constipation: a view from 2015 and beyond
Gabrio Bassotti et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Application of Pyridostigmine in Pediatric Gastrointestinal Motility Disorders: A Case Series
Mhd Louai Manini et al.
PEDIATRIC DRUGS (2018)
Presentation and Epidemiology of Gastroesophageal Reflux Disease
Joel E. Richter et al.
GASTROENTEROLOGY (2018)
Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review
Natalia Pittman et al.
RHEUMATOLOGY (2018)
Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial
Chingching Foocharoen et al.
RHEUMATOLOGY (2017)
Mirtazapine for symptom control in refractory gastroparesis
Mark Malamood et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Spectrum of esophageal dysmotility in systemic sclerosis on high-resolution esophageal manometry as defined by Chicago classification
N. Aggarwal et al.
DISEASES OF THE ESOPHAGUS (2017)
Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts
Elizabeth R. Volkmann et al.
BMJ OPEN GASTROENTEROLOGY (2017)
Oesophageal dysphagia: a stepwise approach to diagnosis and management
Brian T. Johnston
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study
Barbara Vigone et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015
Katsuhiko Iwakiri et al.
JOURNAL OF GASTROENTEROLOGY (2016)
The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial
George P. Karamanolis et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Fructose Malabsorption in Systemic Sclerosis
Isabelle Marie et al.
MEDICINE (2015)
Systemic Sclerosis Gastrointestinal Disease and Its Management
Genevieve Gyger et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2015)
High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders
J. Pablo Abonia et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Agreement with Guidelines from a Large Database for Management of Systemic Sclerosis: Results from the Canadian Scleroderma Research Group
Janet Pope et al.
JOURNAL OF RHEUMATOLOGY (2012)
Early endoscopy in systemic sclerosis without gastrointestinal symptoms
Rene Thonhofer et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Efficacy of Linaclotide for Patients With Chronic Constipation
Anthony J. Lembo et al.
GASTROENTEROLOGY (2010)
Efficacy and Safety of Once Daily Linaclotide Administered Orally for 12-Weeks in Patients With Chronic Constipation: Results From 2 Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials
Anthony Lembo et al.
GASTROENTEROLOGY (2010)
Often forgotten manifestations of systemic sclerosis
Ami A. Shah et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2008)
Comparison of surgical approaches to recalcitrant Gastroesophageal reflux disease in the patient with scleroderma
Michael S. Kent et al.
ANNALS OF THORACIC SURGERY (2007)
Sjogren's syndrome is associated with and not secondary to systemic sclerosis
Carine Salliot et al.
RHEUMATOLOGY (2007)
Sacral nerve stimulation for faecal incontinence due to systemic sclerosis
NJ Kenefick et al.
GUT (2002)
AGA technical review on nausea and vomiting
EMM Quigley et al.
GASTROENTEROLOGY (2001)
分享论文
